Longitudinal Assessment of Enhancing Foci of Abnormal Signal Intensity in Neurofibromatosis Type 1 [PEDIATRICS]
CONCLUSIONS:
Albeit very rare, contrast-enhancing lesions in patients with neurofibromatosis 1 may regress over time. Follow-up MR imaging aids in ascertaining regression. The development of atypical features should prompt further evaluation for underlying tumors.
Source: American Journal of Neuroradiology - Category: Radiology Authors: Hainc, N., Wagner, M. W., Laughlin, S., Rutka, J., Hawkins, C., Blaser, S., Ertl-Wagner, B. B. Tags: PEDIATRICS Source Type: research
More News: Astrocytoma | Brain | Brain Cancers | Brain Tumor | Cerebellum | HIV AIDS | Neurofibromatosis | Neurology | Pediatrics | Radiology